NL9201722A - Farmaceutische samenstelling voor de plaatsgebonden afgifte van een stolsel oplossend eiwit en werkwijze voor de bereiding daarvan. - Google Patents

Farmaceutische samenstelling voor de plaatsgebonden afgifte van een stolsel oplossend eiwit en werkwijze voor de bereiding daarvan. Download PDF

Info

Publication number
NL9201722A
NL9201722A NL9201722A NL9201722A NL9201722A NL 9201722 A NL9201722 A NL 9201722A NL 9201722 A NL9201722 A NL 9201722A NL 9201722 A NL9201722 A NL 9201722A NL 9201722 A NL9201722 A NL 9201722A
Authority
NL
Netherlands
Prior art keywords
plasminogen
liposomes
composition
activator
plasminogen activator
Prior art date
Application number
NL9201722A
Other languages
English (en)
Dutch (nl)
Original Assignee
Stichting Tech Wetenschapp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Stichting Tech Wetenschapp filed Critical Stichting Tech Wetenschapp
Priority to NL9201722A priority Critical patent/NL9201722A/nl
Priority to CA002146324A priority patent/CA2146324A1/en
Priority to JP6508918A priority patent/JPH08502060A/ja
Priority to PCT/NL1993/000195 priority patent/WO1994007537A1/en
Priority to DE69321131T priority patent/DE69321131D1/de
Priority to EP93923685A priority patent/EP0662841B1/de
Priority to AU53454/94A priority patent/AU5345494A/en
Priority to AT93923685T priority patent/ATE171073T1/de
Publication of NL9201722A publication Critical patent/NL9201722A/nl
Priority to NO951219A priority patent/NO951219L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/49—Urokinase; Tissue plasminogen activator
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6905—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a colloid or an emulsion
    • A61K47/6911—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a colloid or an emulsion the form being a liposome
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dispersion Chemistry (AREA)
  • Hematology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Actuator (AREA)
  • Structures Of Non-Positive Displacement Pumps (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
NL9201722A 1992-10-05 1992-10-05 Farmaceutische samenstelling voor de plaatsgebonden afgifte van een stolsel oplossend eiwit en werkwijze voor de bereiding daarvan. NL9201722A (nl)

Priority Applications (9)

Application Number Priority Date Filing Date Title
NL9201722A NL9201722A (nl) 1992-10-05 1992-10-05 Farmaceutische samenstelling voor de plaatsgebonden afgifte van een stolsel oplossend eiwit en werkwijze voor de bereiding daarvan.
CA002146324A CA2146324A1 (en) 1992-10-05 1993-10-05 Pharmaceutical composition for the site-specific release of clot-dissolving protein and method for the preparation thereof
JP6508918A JPH08502060A (ja) 1992-10-05 1993-10-05 血餅−溶解タンパク質の部位−特異的放出用医薬組成物
PCT/NL1993/000195 WO1994007537A1 (en) 1992-10-05 1993-10-05 Pharmaceutical composition for site-specific release of a clot-dissolving protein
DE69321131T DE69321131D1 (de) 1992-10-05 1993-10-05 Pharmazeutische zusammensetzung für ortsspezifische abgabe von blutgerinselauflösende proteine
EP93923685A EP0662841B1 (de) 1992-10-05 1993-10-05 Pharmazeutische zusammensetzung für ortsspezifische abgabe von blutgerinselauflösende proteine
AU53454/94A AU5345494A (en) 1992-10-05 1993-10-05 Pharmaceutical composition for site-specific release of a clot-dissolving protein
AT93923685T ATE171073T1 (de) 1992-10-05 1993-10-05 Pharmazeutische zusammensetzung für ortsspezifische abgabe von blutgerinselauflösende proteine
NO951219A NO951219L (no) 1992-10-05 1995-03-30 Farmasöytisk preparat til behandling av blodklumper og fremgangsmåte til fremstilling derav

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
NL9201722 1992-10-05
NL9201722A NL9201722A (nl) 1992-10-05 1992-10-05 Farmaceutische samenstelling voor de plaatsgebonden afgifte van een stolsel oplossend eiwit en werkwijze voor de bereiding daarvan.

Publications (1)

Publication Number Publication Date
NL9201722A true NL9201722A (nl) 1994-05-02

Family

ID=19861342

Family Applications (1)

Application Number Title Priority Date Filing Date
NL9201722A NL9201722A (nl) 1992-10-05 1992-10-05 Farmaceutische samenstelling voor de plaatsgebonden afgifte van een stolsel oplossend eiwit en werkwijze voor de bereiding daarvan.

Country Status (9)

Country Link
EP (1) EP0662841B1 (de)
JP (1) JPH08502060A (de)
AT (1) ATE171073T1 (de)
AU (1) AU5345494A (de)
CA (1) CA2146324A1 (de)
DE (1) DE69321131D1 (de)
NL (1) NL9201722A (de)
NO (1) NO951219L (de)
WO (1) WO1994007537A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030220233A1 (en) 1994-01-24 2003-11-27 Neorx Corporation Radiolabeled annexins
US5968477A (en) * 1994-01-24 1999-10-19 Neorx Corporation Radiolabeled annexin conjugates with hexose and a chelator
DE19529223A1 (de) * 1995-08-09 1997-02-13 Boehringer Mannheim Gmbh Verwendung von Plasminogenaktivatoren zum lokalen Knochenaufbau
KR102897177B1 (ko) * 2019-04-12 2025-12-05 유지엘엑스 리서치 에이비 장기 복구를 위한 방법 및 장치
EP3952644B1 (de) * 2019-04-12 2025-09-24 UGLK Science AB Verfahren und vorrichtung zur rekonditionierung von nieren

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE831867A (fr) * 1975-07-29 1976-01-29 Association d'un activateur du plasminogene, d'une part, et du plasminogene lui-meme
JPS52102975A (en) * 1976-02-24 1977-08-29 Toyota Motor Corp Hydraulic driving system
US4193983A (en) * 1978-05-16 1980-03-18 Syva Company Labeled liposome particle compositions and immunoassays therewith
DE3682754D1 (de) * 1985-12-16 1992-01-16 Ethicon Inc Hemmung von post-chirurgischer adhaesionsbildung durch topische verabreichung von gewebeplasminogenaktivator.
US5000960A (en) * 1987-03-13 1991-03-19 Micro-Pak, Inc. Protein coupling to lipid vesicles
JP2764264B2 (ja) * 1987-10-01 1998-06-11 株式会社ミドリ十字 線溶活性増強剤
US5013556A (en) * 1989-10-20 1991-05-07 Liposome Technology, Inc. Liposomes with enhanced circulation time

Also Published As

Publication number Publication date
ATE171073T1 (de) 1998-10-15
AU5345494A (en) 1994-04-26
CA2146324A1 (en) 1994-04-14
NO951219L (no) 1995-06-06
EP0662841B1 (de) 1998-09-16
JPH08502060A (ja) 1996-03-05
NO951219D0 (no) 1995-03-30
DE69321131D1 (de) 1998-10-22
EP0662841A1 (de) 1995-07-19
WO1994007537A1 (en) 1994-04-14

Similar Documents

Publication Publication Date Title
Koudelka et al. Liposomal nanocarriers for plasminogen activators
US10357448B2 (en) Echogenic vehicle for clinical delivery of plasminogen activator and other fibrin-binding therapeutics to thrombi
ES2241030T3 (es) Preparado farmaceutico para el tratamiento de alteraciones de la coagulacion sanguinea.
Heeremans et al. Thrombolytic treatment with tissue-type plasminogen activator (t-PA) containing liposomes in rabbits: a comparison with free t-PA
US20090047356A1 (en) Tissue factor compositions and methods
US12161698B2 (en) Synthetic platelets
US20030134778A1 (en) Pharmaceutical composition comprising factor VIII and neutral liposomes
Elbayoumi et al. Liposomes for targeted delivery of antithrombotic drugs
MXPA03008864A (es) Composicion de liposoma para el suministro intracelular mejorado en un agente terapeutico.
AU785103B2 (en) Stabilized liquid preparation of the protease which activates blood coagulation factor VII, or of its proenzyme
JPH026405A (ja) 経肺薬物送達用組成物
JP2002515447A (ja) 抑制されない血管内フィブリンクロット形成の予防および治療のための組成物および方法
Vaidya et al. Platelets directed liposomes for the delivery of streptokinase: development and characterization
Kim et al. Prolonged systemic delivery of streptokinase using liposome
Chiu et al. Targeting of antibody conjugated, phosphatidylserine-containing liposomes to vascular cell adhesion molecule 1 for controlled thrombogenesis
US5658588A (en) Fibrinogen-coated liposomes
EP0662841B1 (de) Pharmazeutische zusammensetzung für ortsspezifische abgabe von blutgerinselauflösende proteine
US20030147944A1 (en) Lipid carrier compositions with protected surface reactive functions
WO2009067407A2 (en) Compositions of matrix metalloproteinase activating endopeptidases for reducing intraocular pressure, and methods of use thereof
US20250134969A1 (en) Biosynthetic hemostat and uses thereof
CA2994891C (en) Pharmaceutical formulations of pegylated liposomes and blood coagulation factors
KR20240042134A (ko) A형 혈우병 치료용 변형된 콜로이드 입자
WO1994013323A1 (en) Method of inhibiting the clearance of liposomes from the circulation
Costello et al. The extracellular control of intracellular aspirin hydrolysis
Chiu Liposomes with selective and controllable surface reactivity: Applications for tumor specific thrombosis

Legal Events

Date Code Title Description
A1B A search report has been drawn up
BV The patent application has lapsed